The U.S. cannabis industry reports its first job loss
The U.S. legal cannabis industry is showing clear signs of maturing and facing challenges as employment and revenue decline for the first time.
According to the latest Report on Employment in the U.S. Cannabis Industry, 2026, thecannabis industry In the United States, the industry is entering a phase characterized less by rapid expansion than by consolidation, efficiency gains, and tighter margins.
The first nationwide decline in employment and revenue
The report, prepared by the Vangst recruitment platform and the research firm Whitney Economics estimates that the workforce in the legal cannabis industry fell to approximately 412,500 jobs in early 2026, a decrease of 2.7 % compared with the previous year.
At the same time, retail cannabis sales in the United States fell to $29.1 billion in 2025, marking the first year-over-year decline since adult-use legalization began in 2014. The report also notes a 3.3 % decline in overall sales, reinforcing the impression of a market under pressure rather than one that is expanding.
This double contraction is viewed less as a collapse than as a structural shift. As economist Beau Whitney explains, the sector is behaving like a maturing consumer market, where growth slows once initial demand has been met.
«Growth is sustained as long as we continue to shift consumers from the unregulated market to the regulated market,» he said.
But this transition seems to be reaching its limits.
«Most have now converted as many consumers as they can; so there isn’t much room for growth left, unless they change the way cannabis is distributed,» he added.
Price pressure and oversupply are reshaping the industry
One of the main factors behind the slowdown is the ongoing price pressure in several U.S. states. Excess supply in high-production markets continues to drive wholesale prices below production costs, putting pressure on operators from both sides.
«In the United States, we are facing an oversupply, which is driving down prices,» Mr. Whitney said. «Prices are below the cost of production.»
Despite stable—or even slightly increasing—shopping-cart volumes in some states, consumers are spending less overall per transaction. This trend creates a paradox: demand remains stable, but revenue per sale is declining. As a result, operators are forced to cut costs, streamline their workforces, and, in some cases, rely on seasonal labor for harvest and processing cycles.
The report also highlights broader inflationary pressures that extend beyond the product itself. Rising costs for fuel, utilities, and services are eroding already-thin margins, while consumers are benefiting from lower-priced average shopping baskets.
«Despite these challenges and the turbulence, the growth of the cannabis industry continues to generate a significant number of jobs,» notes Beau Whitney. «We’re seeing a bit of a slowdown, but this happens every time a market matures. Most of the growth occurs in the early stages.»
A Geography of Contrasts: Mature Markets vs. Emerging Markets
The decline is not evenly distributed. Mature markets such as California, Colorado, Oregon, and Michigan are seeing job losses, while newer markets continue to create jobs.
California remains the top employer with 57,500 jobs, followed by Michigan with 42,500.
In contrast, emerging economies are still in a phase of expansion. New York, which most recently legalized, stands out with a 1,29% increase in employment, creating more than 16,000 jobs to reach a total of 28,660. Maryland and Ohio also recorded significant increases, helping to offset losses in more established markets.
As Ryan Rosenfeld of Vangst puts it: «It may seem like a matter of geography, but it’s actually a matter of maturity.»
He adds that mature states are moving toward greater efficiency: «California and Michigan are becoming more efficient as operators adapt to price pressures and optimize their workforces. Meanwhile, New York, Maryland, and Ohio are still in the growth phase.»
Regulatory Uncertainty and Long-Term Outlook
Beyond market forces, federal policy remains a major factor. A possible reclassification to Category 3 could alleviate the tax burden imposed by IRS Section 280E, potentially freeing up capital for expansion, price adjustments, or debt reduction.
Analysts predict, however, that a partial reform could also introduce new complexities. A separation between the medical and recreational markets could shift certain parts of the supply chain toward a pharmaceutical-style distribution model, including sales in pharmacies and stricter compliance standards.
Whitney also notes that not all operators will be able to meet future requirements for good manufacturing practices (GMP) or agricultural certification, which could accelerate consolidation.
Despite a short-term decline, long-term projections remain significant. In a scenario of full decriminalization, the sector could theoretically generate up to 1.6 million jobs. Today, however, legal sales still account for only about 30% of total demand, leaving a significant portion of the activity in illegal channels.
The key challenge for the legal cannabis market remains the same: to convert this demand into regulated sales without prices becoming unaffordable.
-
Cannabis in France3 weeks ago
France Sets July as the Deadline for the Widespread Adoption of Medical Cannabis
-
Cannabis in Europe2 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Business4 weeks ago
Eight years after legalization, South African cannabis is still waiting for its legal market
-
Cannabis in France4 weeks ago
French Prime Minister Calls for Drug Testing in Government Ministries
-
Cannabis in Ukraine4 weeks ago
Ukraine Issues Its First Medical Cannabis Prescriptions to Veterans
-
Business4 weeks ago
Sanity Group is expanding its presence in Switzerland through a distribution agreement with Astrasana
-
Cannabis in the U.S.2 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Cannabis in Ireland3 weeks ago
The Irish Parliament recommends decriminalizing all drugs


You must be logged in to post a comment Login